BioNTech
BNTX
BNTX
277 hedge funds and large institutions have $4.71B invested in BioNTech in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 100 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
277
Holders Change
-23
Holders Change %
-7.67%
% of All Funds
3.76%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
39
Increased
73
Reduced
100
Closed
57
Calls
$137M
Puts
$157M
Net Calls
-$19.9M
Net Calls Change
-$124M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$63.3M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$52.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$50.8M |
| 4 |
Millennium Management
New York
|
+$34M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$33.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$38.1M |
| 2 |
FAM
Fred Alger Management
New York
|
-$36.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.8M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$35.3M |
| 5 |
Primecap Management
Pasadena,
California
|
-$22.7M |
